PS
CRVO icon

Principal Securities’s CervoMed CRVO Stock Holding History

Principal Securities’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,665
Closed -$13.5K – 1786
2025
Q3 		$13.5K Buy
1,665
+1,500
+909% +$12.9K ﹤0.01% 2598
2025
Q2 		$1.04K Buy
+165
New +$1.41K ﹤0.01% 3324

Other funds holding CRVO

AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return

Principal Securities's CRVO Position: Q4 2025 in Review

Principal Securities sold out of CervoMed (CRVO) in Q4 2025, closing a stake of 1,665 shares — an estimated $13.5K sold.

Principal Securities first reported a position in CRVO in Q2 2025 and held it in 2 quarters. The position peaked at $13.5K in Q3 2025. 48 funds tracked by Wall St. Rank hold CRVO as of Q4 2025.

  • Principal Securities reported no remaining CervoMed position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 1,665 CervoMed shares in Q4 2025, an estimated $13.5K.
  • Principal Securities first reported a position in CervoMed in Q2 2025 and held it in 2 quarters.
  • Principal Securities's CervoMed position peaked at $13.5K in Q3 2025.
  • 48 funds tracked by Wall St. Rank held CervoMed as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.